Srikakulam

The successful completion of the project is not only crucial for the lenders but also PTC India and its subsidiary PTC Financial Services in which it has a 64.99 percent stake

Dr Reddy's gears up for key USFDA audits in next 2 months: Srcs

Drug maker Dr Reddy‘s Laboratories will be put to a crucial test in the second week of April as the company gears up for major USFDA audits at its facilities in Srikakulam located some 70 kms away from port city of Visakhapatnam.

Lenders seek Andhra govt help in saving Rs 10,500-cr power plant

The Andhra Pradesh government may come to the rescue of the 12 lenders of the Rs 10,500-crore under-construction 1,320 MW power project at Kakarapalli village in the state‘s Srikakulam district, according to a source.

US FDA issues shouldn't be overbearing factor for pharma: Citi

Executives of Dr Reddy's Laboratories and Citi tell CNBC-TV18 that the second half of 2016 should be a good one for pharma industry.

Dr Reddy's Q4 profit may rise 6%, warning letters resolution key

During the period, EBITDA may grow 11.2 percent to Rs 897 crore versus Rs 806.4 crore while margins may stand at 23 percent versus 21 percent.

See huge opportunity in Venezuela; US supply not restricted: DRL

Saumen Chakraborty, CFO, Dr Reddy's, says the company has been calibrating sales in Venezuala where the market and capacity is huge.

Will resolve issues raised by USFDA in a timely manner: DRL

The drug major had received a warning letter on November 5, 2015 from the USFDA regarding deviations from current good manufacturing practices (CGMP) at its active pharmaceutical ingredient (API) facilities at Srikakulam, Andhra Pradesh and Miryalaguda in Telangana

Dr Reddy's tanks 10% on USFDA warning: How to trade now?

Bank of America Merill Lynch maintains underperfom rating as it feels complete resolution may take 12-18 months. It remains remain cautious on factors such as higher product concentration risks in the US potential, competition in key products and limited pipeline visibility.

USFDA warning: Have 15 days to respond, says DRL CFO

Saumen Chakraborty, CFO, Dr Reddy's Laboratories, says "The warning letter has come telling the management to respond within 15 working days in terms of strategy and plan."

Dr Reddy's gets FDA warning letter for three drug plants

The warning letter was issued by the FDA to Dr Reddy's on Thursday for its Srikakulam, Miryalaguda and Duvvada drug manufacturing plants - all based in southern India.

Dr Reddy's tanks 15% post warning letter from USFDA

The warning letter is relating to its API manufacturing facilities at Srikakulam, Andhra Pradesh and Miryalaguda, Telangana, as well as Oncology Formulation manufacturing facility at Duvvada, Visakhapatnam, Andhra Pradesh.

Crompton Greaves bags Rs 115 crore order from Power Grid

These reactors will be installed at Power Grid's Vemagiri and Srikakulam sub-stations in Andhra Pradesh.

TDP veteran Yerran Naidu dead

Senior TDP leader and former Union Minister K Yerran Naidu died in a road accident early today in his native Srikakulam district in Andhra Pradesh. He was 55.

Exports to grow sizably in 2011: Nagarjuna Agrichem

Nagarjuna Agrichem has reported a sales turnover of Rs 127.48 crore and a net loss of Rs 1.06 crore for the quarter ended Dec '10. For the quarter ended Dec 2009 the sales turnover was Rs 171.41 crore and net profit was Rs 18.32 crore.